Abstract
Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
Keywords: Vasopressin, osmoreceptors, baroreceptors, circumventricular organs, osmolality, central nervous system, anatomical pathways, neurotransmitters, AVP secretion, hypothalamus.
Current Pharmaceutical Design
Title:Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs
Volume: 18 Issue: 30
Author(s): Michele Iovino, Edoardo Guastamacchia, Vito Angelo Giagulli, Brunella Licchelli and Vincenzo Triggiani
Affiliation:
Keywords: Vasopressin, osmoreceptors, baroreceptors, circumventricular organs, osmolality, central nervous system, anatomical pathways, neurotransmitters, AVP secretion, hypothalamus.
Abstract: Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
Export Options
About this article
Cite this article as:
Iovino Michele, Guastamacchia Edoardo, Angelo Giagulli Vito, Licchelli Brunella and Triggiani Vincenzo, Vasopressin Secretion Control: Central Neural Pathways, Neurotransmitters and Effects of Drugs, Current Pharmaceutical Design 2012; 18 (30) . https://dx.doi.org/10.2174/138161212802651607
DOI https://dx.doi.org/10.2174/138161212802651607 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ranolazine, a Partial Fatty Acid Oxidation Inhibitor, its Potential Benefit in Angina and Other Cardiovascular Disorders
Recent Patents on Cardiovascular Drug Discovery Influence of Quaternary Conformation on the Biological Activities of the Asp49-phospholipases A2s from Snake Venoms
Protein & Peptide Letters Recent Insights into COVID-19 in Children and Clinical Recommendations
Current Pediatric Reviews Fibromyalgia Syndrome: Which Antidepressant Drug Should We Choose
Current Pharmaceutical Design Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Enantiomeric Local Anesthetics: Can Ropivacaine and Levobupivacaine Improve Our Practice?
Current Drug Therapy Spontaneous Coronary Artery Dissection: Does Being Unemployed Matter? Insights from the GSCAD Registry
Current Cardiology Reviews Peroxisome Proliferator-Activated Receptor-γ in Vascular Biology
Cardiovascular & Hematological Disorders-Drug Targets Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity
Current Cancer Drug Targets Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Current Drug Therapy Aryltetralin-type Lignan of Podophyllum: A Comprehensive Review
The Natural Products Journal Addiction Liability of Pharmacotherapeutic Interventions in Obesity
Current Pharmaceutical Design Preoperative Levosimendan. A New Way for Organoprotection
Current Pharmaceutical Design Patient-Controlled Analgesia
Current Drug Targets Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Current Cardiology Reviews Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy
Current Pharmaceutical Design Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Reviews on Recent Clinical Trials Long-Acting Antipsychotic Medications
Current Drug Targets ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology